A
Avanos Medical, Inc. (AVNS)
NYQ – Real Time Price. Currency in USD
24.73
-0.08 (-0.32%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NYQ – Real Time Price. Currency in USD
24.73
-0.08 (-0.32%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.48 | 3.40 | 10 | |
| Quick ratio | 1.40 | 2.52 | 7.0 | |
| Debt to Equity | 0.18 | 1.11 | 9.0 | |
| Debt to Assets | 0.13 | 1.58 | 8.0 | |
| Interest coverage | 8.13 | 4.33 | 10 | |
| Weighted average score | 8.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 684M | 673M | 688M | 701M | 716M |
| Gross Profit | 394M | 380M | 381M | 333M | 348M |
| Operating Income | 42M | 65M | 40M | 15M | 35M |
| Net Income | 51M | -62M | -392M | -73M | -74M |
| EBITDA | 83M | 109M | 86M | 54M | 74M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -1.14 | -5.88 | 1.0 |
| Next quarter | 1.8 | 50 | 6.5 |
| Current year | 1.25 | 6.38 | 4.0 |
| Next year | 4.23 | 25 | 7.0 |
| Weighted average score | 4.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 0.72 | 492.31 | -24.13 | -177.92 | 3.5 |
| Y/Y | 8.78 | -22.72 | -15.37 | -187.36 | 2.3 |
| 3y average | 0.84 | -225.13 | -12.28 | 113.4 | 3.5 |
| 5y average | -0.27 | 29.87 | 10.44 | 148.05 | 7.0 |
| Weighted average score | 4.1 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $138.4M significantly exceeds cash reserves ($65.6M), raising financial stability concerns
Total current assets $325.0M exceed Total current liabilities $131.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (1.1), showcasing prudent financial management
Interest coverage ratio (8x) indicates the company easily manages its debt payments
Negative free cash flow -$16.6M limits the company's ability to reinvest or pay down debt